Effect of Low-dose, Enteric Coated Aspirin on Gastrointestinal Bleeding in Patients with Coronary Artery Disease

참고문헌 (28)

1. Antiplatelet Trialist’ Collaboration, "Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients", BMJ, 308, pp.81~106 (1994)
2. Steering Committee of the Physicians’ Health Study Research Group, "Final report on the aspirin component of the ongoing Physician’s Health Study", N Engl J Med, 323, pp.1289~1298 (1989)
3. The SALT Collaborative Group, "Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular events", Lancet, 338, pp.1345~1353 (1991)
4. Lorenz RL, "Improved aortocoronary bypass patency by low-dose aspirin (100 mgr. daily): Effects of platelet aggregation and thromboxane formation", Lancet, 1, pp.1261~1264 (1984)
5. Weil J, "Prophylactic aspirin and risk of peptic ulcer bleeding", BMJ, 310, pp.827~830 (1995)
6. Slattery J, "Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin--analysis of gastrointestinal bleeding during the UK-TIA trial", Gut, 37, pp.509~511 (1995)
7. Kelly JP, "Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product", Lancet, 348, pp.1413~1416 (1996)
8. Lanas A, "Nitrovasodilators, low dose aspirin, nonsteroidal anti-inflammatory drugs, and the risk of upper gastrointestinal bleeding", N Engl J Med, 343, pp.834~839 (2000)
9. Lanas A, "Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment", Curr Med Res Opin, 23, pp.163~173 (2007)
10. Hallas J, "Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study", BMJ, 333, pp.712~713 (2006)
11. Naylor GM, "Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients", Gut, 55, pp.1545~1552 (2006)
12. Hawkey CJ, "Nonsteroidal anti-inflammatory drug gastropathy", Gastroenterology, 119, pp.521~535 (2000)
13. Serrano P, "Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases", Aliment Pharmacol Ther, 16, pp.1945~1953 (2002)
14. Wallace JL, "Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years", Gastroenterology, 112, pp.1000~1016 (1997)
15. Lee M, "dose effects of aspirin on gastricprostaglandins and stomach mucosal injury", Ann Intern Med, 120, pp.184~189 (1994)
16. Cryer B, "Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans", Gastroenterology, 117, pp.17~25 (1999)
17. Fox KA, "Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non-ST-Elevation Acute Coronary Syndrome", Circulation, 110, pp.1202~1208 (2004)
18. McQuaid KR, "Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials", Am J Med, 119, pp.624~638 (2006)
19. Liberopoulos EN, "Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and", or clopidogrel: where we are now?, 2006, pp.17, 1~6
20. Wolfe MM, "Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs", N Engl J Med, 340, pp.1888~1899 (1999)
21. Silverstein FE, "Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double blind, placebo- controlled trial", Ann Intern Med, 123, pp.241~249 (1995)
22. Gabriel SE, "Risk for serious gastrointestinal complications related to the use of nonsteroidal anti-inflammatory drugs. A meta-analysis", Ann Intern Med, 115, pp.787~796 (1991)
23. Laine L, "Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis", Gastroenterology, 123, pp.1006~1012 (2002)
24. Laine L, "Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial", Aliment Pharmacol Ther, 9, pp.127~135 (1995)
25. Labenz J, "Helicobacter pylori increases the risk of peptic ulcer bleeding: a case control study", Ital J Gastroenterol Hepatol, 31, pp.110~115 (1999)
26. Wu CY, "Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding", Scand J Gastroenterol, 34, pp.234~237 (1999)
27. Chan FK, "How does Helicobacter pylori infection interact with non-steroidal anti-inflammatory drugs?", Baillieres Clin Gastroenterol, 14, pp.161~172 (2000)
28. Hawkey CH, "Helicobacter pylori and non-steroidal anti-inflammatory drugs, In Helicobacter pylori: basic mechanisms to clinical cure 2000", pp.461~466 (2000), Kluwer Academic Publishers

관련 논문AI추천